COMP <GO>
ONTO vs CGNX // EV/EBITDA & P/E VALUATION
Onto Innovation Inc. (NYSE) VS. Cognex Corporation (NASDAQ) • 15-METRIC TALLY: ONTO 4
— CGNX 9
▲ EV/EBITDA & P/E VALUATION LEADER: CGNX
LAST: $201.57 (-9.16%) • MKT CAP: $10.89B
valuation
67.8x
LAST: $56.15 (-4.78%) • MKT CAP: $9.92B
valuation
58.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ONTO VS. CGNX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ONTO | CGNX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 49.70% | 66.90% | -17.20 | CGNX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.60% | 8.90% | -3.30 | CGNX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 67.8x | 58.1x | +9.70 | CGNX | /valuation <GO> |
| Free Cash Flow Yield | 2.75% | 2.39% | +0.36 | ONTO | /fcf-yield <GO> |
| Operating Margin | 13.20% | 16.30% | -3.10 | CGNX | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 11.50% | -11.50 | CGNX | /net-margins <GO> |
| Revenue Growth (YoY) | 1.80% | 8.70% | -6.90 | CGNX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.55% | -0.55 | CGNX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 12.69 | +13.31 | ONTO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | CGNX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.6 | 50.9 | -8.30 | CGNX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 0.88 | +0.22 | ONTO | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 80.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.89B | $9.92B | $968.9M | ONTO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ONTO REV | CGNX REV | ONTO GROSS % | CGNX GROSS % | ONTO FCF | CGNX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.01B | $994.4M | 49.7% | 66.9% | $299.8M | $236.8M |
| FY 2024 | $987.3M | $914.5M | 52.2% | 68.4% | $213.8M | $134.0M |
| FY 2023 | $815.9M | $837.5M | — | — | $135.3M | $75.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ONTO // BETA 1.10
CGNX // BETA 0.88